电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

SARS-CoV Spike 抗体

This anti-SARS-CoV Spike antibody is a 小鼠 单克隆 antibody detecting SARS-CoV Spike in Neut. Suitable for SARS Coronavirus (SARS-CoV).
产品编号 ABIN7794778
发货至: 中国

Quick Overview for SARS-CoV Spike 抗体 (ABIN7794778)

抗原

See all SARS-CoV Spike (SARS-CoV S) 抗体
SARS-CoV Spike (SARS-CoV S) (SARS-Coronavirus Spike Protein (SARS-CoV S))

适用

  • 51
  • 16
  • 1
SARS Coronavirus (SARS-CoV)

宿主

  • 42
  • 9
  • 1
小鼠

克隆类型

  • 42
  • 10
单克隆

标记

  • 31
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This SARS-CoV Spike antibody is un-conjugated

应用范围

  • 26
  • 19
  • 6
  • 5
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Neutralization (Neut)

克隆位点

COV1-80
  • 原理

    Anti-SARS-CoV-1, Spike (Clone COV1-80)-Purified No Carrier Protein

    特异性

    COV1-80 targets the prefusion spike protein of SARS-CoV-1 and SARS-CoV-2. Antigen Distribution Anti-SARS-CoV-1 recognizes antigens on infected cells, including respiratory epithelial cells. Background SARS-CoV-1, also known as the Severe Acute Respiratory Syndrome coronavirus, is a zoonotic virus that is believed to have originated from an animal reservoir, possibly horseshoe bats, and transmitted to humans1. This virus primarily affects the respiratory system and can cause symptoms such as muscle pain, headache, fever, cough, dyspnea, and pneumonia1,2. It was the first severe and readily transmissible new disease to emerge in the 21st century, with the capacity to spread globally via international air travel. The COV1-80 monoclonal antibody is cross-reactive, targeting the spike protein of both SARS-CoV-1 and SARS-CoV-2. While it does not block the ACE2 receptor, COV1-80 still functions as a neutralizing antibody, meaning it can inhibit the virus's capacity to infect host cells. The exact epitope that COV1-80 binds to remains unidentified, highlighting the need for further research to understand its mechanism of action fully. Nonetheless, the demonstrated neutralizing activity of COV1-80 makes it a promising candidate for therapeutic strategies, particularly in combination therapies that target multiple viral epitopes for enhanced effectiveness.

    纯化方法

    Recombinant antibodies are manufactured in an animal free facility using only in vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.

    纯度

    >=90 % monomer by analytical SEC and SDS-Page

    亚型

    IgG1 lambda
  • 限制

    仅限研究用
  • 浓度

    1 μg/mL

    缓冲液

    This recombinant monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.

    储存液

    Without preservative

    储存条件

    4 °C,-80 °C

    储存方法

    This antibody may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at <= -70°C.Avoid Repeated Freeze Thaw Cycles.
  • 抗原

    SARS-CoV Spike (SARS-CoV S) (SARS-Coronavirus Spike Protein (SARS-CoV S))

    别名

    SARS-CoV Spike

    物质类

    Viral Protein
You are here:
Chat with us!